As previously reported a little over a year ago, BioSante Pharmaceuticals is trying to re-initiate the development of the GVAX vaccine product for the treatment of prostate cancer. … READ MORE …
Filed under: Drugs in development, Management, Treatment | Tagged: GVAX | Leave a comment »
In another severe setback for the application of immunotherapy in the treatment of advanced prostate cancer, Cell Genesys has announced the early termination of the Phase III VITAL-2 clinical trial comparing GVAX + docetaxel to docetaxel + prednisone. … READ MORE …
Filed under: Drugs in development, Treatment | Tagged: cancer, GVAX, news, prostate, update | 2 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 